go back

Indiana rates for HCPCS Q2053

Brexucabtagene autoleucel, up to 200 million autologous anti-CD19 CAR positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $0 · 10th–90th $0–$1,380,3840%50%90th$0Professionalmedian $489,779 · 10th–90th $489,779–$588,8440%50%90th$489,779$0.0$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $1,380,384.26 / $2,238,721.14
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $575,439.94
Anthem BCBS
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$0.02 / $0.02 / $575,439.94
Anthem BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $794,328.23
CareSource
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $588,843.66 / $870,963.59
CareSource
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$489,778.82 / $489,778.82 / $489,778.82
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$467,735.14 / $489,778.82 / $588,843.66
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$489,778.82 / $977,237.22 / $977,237.22
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$371,535.23 / $489,778.82 / $562,341.33